Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1–5 of a 3-weekly cycle in patients with advanced solid tumours - Concepedia

Concepedia

Publication | Open Access

Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1–5 of a 3-weekly cycle in patients with advanced solid tumours

DOI Full Paper Access

19

Citations

17

References

2004

Year

Maja J.A. de Jonge, Stan B. Kaye, Jaap Verweij, C. Brock, Sarah Reade, Michelle Scurr, Leni van Doorn, C D G W Verheij, Walter J. Loos, C. Brindley,

British Journal of Cancer

References

	Year	Citations

Page 1